Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation - Test2 - elhamkhani - TriplyDB

Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation

Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation

http://www.wikidata.org/entity/Q33518352

about

Role of plasma kallikrein in diabetes and metabolism Endothelial Microparticles Act as Novel Diagnostic and Therapeutic Biomarkers of Diabetes and Its Complications: A Literature Review Increased microparticle production and impaired microvascular endothelial function in aldosterone-salt-treated rats: protective effects of polyphenols.Circulating microparticles: square the circle.Quantitating the subtleties of microglial morphology with fractal analysis.Thrombosis and Hemorrhage in Diabetic Retinopathy: A Perspective from an Inflammatory Standpoint Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?Immobilization and detection of platelet-derived extracellular vesicles on functionalized silicon substrate: cytometric and spectrometric approach Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging.Microglial microvesicle secretion and intercellular signaling.The emerging roles of microvesicles in liver diseases.Pathogenic roles of microvesicles in diabetic retinopathy.Extracellular Vesicles and Vascular Injury: New Insights for Radiation Exposure.Endothelial microparticles act as novel diagnostic and therapeutic biomarkers of circulatory hypoxia-related diseases: a literature review.High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation.Oxidized low-density lipoprotein-induced microparticles promote endothelial monocyte adhesion via intercellular adhesion molecule 1.Applicability of extracellular vesicles in clinical studies.Characterization of microparticles in patients with venous malformations of the head and neck.Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo.Association of Metformin Treatment with Reduced Severity of Diabetic Retinopathy in Type 2 Diabetic Patients.

P2860

Q27016431-F2822D29-9B68-46B5-9DFB-FE0D6FC91952 Q28071774-0E3D7279-288E-4E26-8882-70ED2D73B115 Q34341545-23FBDC7B-8877-4962-937C-FD7344A0D971 Q34680832-AECE2A48-B38D-4173-BFC8-6DD8B9F6E31F Q36572876-FE4065F8-DF6E-4B84-88FB-BEB976199211 Q36612276-CF607DFA-6454-4665-BC7E-6903410F7A35 Q36745194-6EDC4243-4333-4F14-B433-6EDA275DA7B9 Q37295504-3219F31D-6F8E-4490-BFAC-49FE4A18E928 Q37601472-74D292CB-6865-4DB1-9B57-561FD1519929 Q38012180-E4894BFF-F6D3-4AFD-9E86-B9DEB3C81C44 Q38015845-CAACB70D-51F7-4149-AAD4-AB3448658918 Q38184831-25D05BBD-DD49-45F7-850D-EC056E11B7A8 Q38656787-EABFDE8F-AD43-4ED1-9928-0DABF1608442 Q38908954-82331C30-5A15-4E20-898B-6A9141202B17 Q39186270-4406FF3E-15DD-4B6F-88B1-66CB552A75F5 Q45027017-4D294A83-9E17-49AF-B22A-A5586AC550D0 Q47787820-9BFF8C6A-FB7D-4590-A3EC-986082626FDE Q48280242-373F1E4D-DAF9-4300-88BD-6F2106D5E063 Q51767823-CE7078D7-8B67-41CC-812B-1D66EFEB34B4 Q54122676-BC0B8BB1-D37A-41FE-A805-76A4CBD486A1 Q55102286-1D4A704E-7B61-4094-BA1E-37F257CB14BA

P2860

Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation

http://www.wikidata.org/entity/Q33518352

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Increased vitreous shedding of ...... ates endothelial proliferation

@ast

Increased vitreous shedding of ...... ates endothelial proliferation

@en

Increased vitreous shedding of ...... tes endothelial proliferation.

@nl

type

label

Increased vitreous shedding of ...... ates endothelial proliferation

@ast

Increased vitreous shedding of ...... ates endothelial proliferation

@en

Increased vitreous shedding of ...... tes endothelial proliferation.

@nl

prefLabel

Increased vitreous shedding of ...... ates endothelial proliferation

@ast

Increased vitreous shedding of ...... ates endothelial proliferation

@en

Increased vitreous shedding of ...... tes endothelial proliferation.

@nl

P1433

Q33518352-1ED6D1FA-12C9-49E8-972A-7382AE079E90

P1476

Q33518352-169925ED-BD4F-4DEC-95ED-E756439DE3FB

P2093

Q33518352-3BB37806-C190-4829-ADCD-CBDC5504A006

Q33518352-5B0873FF-78DA-4205-AA2D-621F35AB4EEA

Q33518352-669ED9B5-B6E2-4354-9389-E416040CB2A5

Q33518352-7718B0BB-B8DA-4AF7-B0E5-06A1E370B584

P2860

Q33518352-0CB39F2C-3A8B-4DD3-9C6B-E0ECC8F3A451

Q33518352-11A5AE2D-58FF-47ED-858E-C5049EF062D4

Q33518352-16D54F16-C05D-4743-AD87-EBBF4EEE05B4

Q33518352-21B5249D-2EDF-4325-9ADD-CB1420602BB2

Q33518352-21C67D68-8517-4463-AA18-C83372C610CB

Q33518352-22232AE8-82C9-4540-82D5-21E092F742B3

Q33518352-259B3A7D-4077-42D1-AE6B-77F141B99144

Q33518352-27C3A873-A8BC-4CA6-9754-B6D94C2DEEF3

Q33518352-2B4F052C-949B-4F1D-930F-03DA147E38A6

Q33518352-34817340-7940-4AF3-984E-9446A6A1F2FC

P304

Q33518352-D7FCA674-61E6-4CD9-B61B-F1B8B82026D4

P31

Q33518352-625D3823-1D7A-4B33-B9DD-9D69946A88C8

P356

Q33518352-B5D5AED9-7CAD-481C-9B27-4DB3F3EEEBC3

P407

Q33518352-8265E386-2120-429A-9A78-4A7C527ABAFB

P433

Q33518352-DD6062CE-AD3D-4498-9090-29FB9C594ABB

P478

Q33518352-CD652C60-7F55-4E26-BE42-CF6B9B555AA8

P50

Q33518352-51E30D62-F3F4-47D0-BBFF-3BA68471EE04

Q33518352-5B956039-E0A5-4289-93C4-45AAED4A8635

Q33518352-B75E5D82-1B23-4440-B680-CFCAFC4A385E

Q33518352-BE15B009-2FE4-4DF9-A14F-BDC2A6F970A4

Q33518352-CF254AFB-8A9E-4146-9D75-00F4E46E4DE7

Q33518352-E52349B2-2AD6-4D33-98CC-5A37DEE70964

Q33518352-FAC8AC71-5874-478C-AEE2-671D50FAAEC0

P577

Q33518352-F10E677F-97E2-4A6B-A02C-D8EEC0952D6D

P5875

Q33518352-861C8CD9-3402-47A2-96C5-F2BF25293B5F

P698

Q33518352-F80BC082-E729-44EC-8090-CA023226CB41

P921

Q33518352-6009799D-BA3C-4D88-A9BF-B6B4AE3D5E8B

P932

Q33518352-80A383C6-76D3-4AE2-9D0D-756623FF43E6

P356

P1433

P1476

Increased vitreous shedding of ...... ates endothelial proliferation

@en

P2093

David Gaucher

http://www.w3.org/2001/XMLSchema#string

Mounir Benzerroug

http://www.w3.org/2001/XMLSchema#string

Pascale Massin

http://www.w3.org/2001/XMLSchema#string

Sadri Chahed

http://www.w3.org/2001/XMLSchema#string

P2860

Histochemical localisation of a galactose-containing glycoconjugate expressed by sensory neurones innervating different peripheral tissues in the rat.

Ocular oxygenation and the treatment of diabetic retinopathy.

Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy.

Microparticles in cardiovascular diseases.

Membrane microparticles: two sides of the coin.

Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage.

Vascular endothelial growth factors and angiogenesis in eye disease.

A new view of diabetic retinopathy: a neurodegenerative disease of the eye.

Retinal angiogenesis in development and disease.

Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease.

P304

694-701

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB08-1524

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Sébastien Silvestre

Adriana Georgescu

Chantal M Boulanger

Aurelie S Leroyer

P577

2009-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40686800

http://www.w3.org/2001/XMLSchema#string

P698

20009085

http://www.w3.org/2001/XMLSchema#string

P921

P932

2828666

http://www.w3.org/2001/XMLSchema#string